AtriCure Inc (ATRC, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices. AtriCure Inc has a market cap of $1.52 billion; its shares were traded at around $38.43 with and P/S ratio of 6.27. AtriCure Inc had annual average EBITDA growth of 5.40% over the past five years. GuruFocus has detected 2 severe warning signs with AtriCure Inc. .
For the last quarter AtriCure Inc reported a revenue of $61.3 million, compared with the revenue of $52.89 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $230.8 million, an increase of 14.5% from last year. For the complete 30-year financial data, please go here.. For the last five years AtriCure Inc had an average revenue growth rate of 16.2% a year.
The reported loss per diluted share was 94 cents for the year, compared with the loss per share of $1.05 in the previous year. The AtriCure Inc had an operating margin of -14.35%, compared with the operating margin of -8.49% a year before. The 10-year historical median operating margin of AtriCure Inc is -13.80%. The profitability rank of the company is 3 (out of 10).
At the current stock price of $38.43, AtriCure Inc is traded at 80.4% premium to its historical median P/S valuation band of $21.30. The P/S ratio of the stock is 6.27, while the historical median P/S ratio is 3.47. The stock gained 15.75% during the past 12 months.
CEO Recent Trades:
- President, CEO, & Director Michael H Carrel sold 25,000 shares of ATRC stock on 02/14/2020 at the average price of $44. The price of the stock has decreased by 12.66% since.
- President, CEO, & Director Michael H Carrel sold 25,000 shares of ATRC stock on 02/13/2020 at the average price of $43. The price of the stock has decreased by 10.63% since.
- President, CEO, & Director Michael H Carrel sold 50,000 shares of ATRC stock on 02/11/2020 at the average price of $41.5. The price of the stock has decreased by 7.4% since.
- President, CEO, & Director Michael H Carrel sold 25,000 shares of ATRC stock on 01/29/2020 at the average price of $40. The price of the stock has decreased by 3.93% since.
CFO Recent Trades:
- CFO M. Andrew Wade sold 45,000 shares of ATRC stock on 02/21/2020 at the average price of $39.45. The price of the stock has decreased by 2.59% since.
For the complete 20-year historical financial data of ATRC, click here.
